Navigation Links
David Bagley Joins Histogen as President
Date:1/14/2009

Regenerative Medicine Company Poised for Product and Business Development Successes in the New Year

San Diego, CA (PRWEB) January 14, 2009-- Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, announced today that David Bagley has joined the Company as President. Histogen welcomes Bagley following a year of rapid growth, with product launches, clinical evaluations and a new facility move on the horizon.

"With the launch of Histogen's first product, the creation of an aesthetics division, and talented new members joining the team in 2008, we've laid the groundwork for exciting progress in the coming year," said Dr. Gail Naughton, Histogen CEO and Chairman of the Board. "I am pleased to welcome David Bagley to Histogen, and believe his business experience and background in the field of tissue engineering will be a great asset to Histogen as we move forward."

David Bagley brings more than 20 years of cell biology and tissue engineering industry experience to Histogen. He has been a contributor to operational, scientific and engineering advancements in the development of several technologies including cell culture, tissue engineered and cell-based products for the treatment of multiple critical diseases, wound care and aesthetic product applications.

Most recently, Bagley served as Vice President and General Manager for Allergan Medical, Inc. with a focus on operations, technology, global distribution, quality and business disciplines. Prior to this, he held positions with Smith + Nephew/Advanced Tissue Sciences for over 12 years, where his latest position was Vice President of Technology and Logistics.

Previously, Bagley worked for Sigma Chemical Company where he was involved in the development and launch of several tissue culture product lines. Early in his career, he worked for Hy
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BrainCells Inc. Appoints David E. Thompson to Its Board of Directors
2. Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast
3. PercSys Names David Auth and Howard Palefsky to Its Board of Directors
4. David H. Murdock Research Institute Taps Waters for Laboratory Technology
5. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
6. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
7. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
8. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
9. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
10. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
11. Omeros Appoints David A. Mann to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... rejection occurs when the transplant recipient,s immune system identifies ... It was previously thought that T cells, the immune ... molecules known as chemokines in order to migrate to ... Journal of Clinical Investigation , Fadi Lakkis and colleagues ... that chemokine stimulation of T cells is not required ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 The new ... Photonics21 at the association’s recent annual meeting drew ... EC Vice-President Neelie Kroes, who called the action “a ... and a stimulant to European innovation.” , The Board ... of the new Photonics PPP at its 29 April ...
(Date:5/17/2013)... PALO ALTO, Calif. , May 17, 2013 ... that it has achieved 50% enrollment of the ... trial to evaluate the safety and preliminary efficacy ... Progenitor Cells) therapy for Knee Osteoarthritis (KOA). To ... Effect (SAE) reported. The Phase I ...
(Date:5/17/2013)...  Insero Health, Inc., a company developing natural compounds ... neurological disorders, is today reporting top-line results from a ... patients with drug-resistant epilepsy.  The data are being presented ... meeting by Dr. Steven Schachter , ... Advisory Board.  In this study, INS001 appeared safe and ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
... Website Tackles Water Safety, Environmental Concerns With Test Kits, Water ... Filters and ... That is the,question. At least it is in the minds of ... aren,t sure if their tap water is,safe. Discover Testing has assembled ...
... REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, ... ), a leader in,the development of microRNA-based ... Scientist Prof. Zvi Bentwich will present AACR,s,upcoming ... Bentwich,s presentation will focus on Rosetta Genomics,unique ...
... Sept. 12 Elekta is pleased to,announce the ... Volumetric Intensity Modulated Arc Therapy (VMAT)*. The complete,offering ... the Elekta booth at,this year,s European Society of ... 2007. Performing VMAT with Elekta,enables helical- like conformality ...
Cached Biology Technology:Discover Testing Settles the Drinking Water Debate: Tap vs. Bottled 2Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference 2Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO 2Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO 3
(Date:5/18/2013)... 2013) The AGA Research Foundation is honored to ... Award in Digestive Cancer, which will support Andrew D. ... the University of Pennsylvania, Philadelphia, as he furthers his ... regeneration and cancer progression. , "The AGA Research Foundation ... two distinguished clinicians and AGA Legacy Society members," said ...
(Date:5/17/2013)... By day, insects provide the white noise of the South, ... typical year, the Southern air hangs heavy from the humidity ... to more than 140 species of frogs, toads and salamanders, ... If the ponds and swamps are the auditorium for their ... Research and Monitoring Initiative, or ARMI, have front-row seats. ...
(Date:5/17/2013)... project (Intelligent Cargo in Efficient and Sustainable Global Logistics ... an improvement in the efficiency of intermodal loading systems ... making. It comprises 29 European organisations with experience in ... has a budget totalling 17,000,000 and a duration of ... to specify and develop the semantic components and ontologies ...
Breaking Biology News(10 mins):AGA Research Foundation grant furthers digestive cancer research 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4New logistics services that will cut energy consumption and CO2 emissions 2
... ORLANDO, Fla., June 30, 2011 Biomechanical testing of ... HULC™ exoskeleton is now underway at the U.S. Army ... Mass.  The testing is expected to help shape future ... (Photo:   http://photos.prnewswire.com/prnh/20110630/FL28804 ) ...
... progenitor cells may not come with a clean genetic slate ... FASEB Journal ( http://www.fasebj.org ) shows that adult stem ... change once a cell differentiates. This is important because epigenetic ... cell,s DNA, but rather, how that DNA functions. Epigenetic changes ...
... California and other premium winegrowing regions of the United ... new study led by Stanford University climate scientists. ... Research Letters , the scientists ,report that by 2040, ... grapes in high-value areas of northern California could shrink ...
Cached Biology News:Lockheed Martin's HULC™ Robotic Exoskeleton Enters Biomechanical Testing at U.S. Army Natick Soldier Systems Center 2Adult stem cells carry their own baggage: Epigenetics guides stem cell fate 2Global warming could alter the US premium wine industry in 30 years, says Stanford study 2Global warming could alter the US premium wine industry in 30 years, says Stanford study 3Global warming could alter the US premium wine industry in 30 years, says Stanford study 4
... NGGC3' 3'CGGN NNNNCCG5' Inactivation Conditions: Heat inactivation ... treatment followed by ethanol precipitation. Storage Conditions: ... EDTA, 1.0mM DTT, 0.01% BSA, 50% glycerol. ... Store at -20C. Unit Definition: One unit ...
...
Anti-Tissue Trans-glutaminase (IgA) EIA Sample Size: 10 l...
... Lysozyme Assay Kit (E-22013) provides,researchers with ... of lysozyme,activity in solution. This fluorescence-based ... 20 U/mL (Figure 1). The assay,measures ... which are labeled to such a ...
Biology Products: